<DOC>
	<DOCNO>NCT01195675</DOCNO>
	<brief_summary>The objective study demonstrate BI 10773 prolong QT ( c ) interval placebo</brief_summary>
	<brief_title>Assessment Effect Empagliflozin ( BI 10773 ) Single Dose QT Interval Healthy Female Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Inclusion criterion : healthy female male subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>